Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join


Nov 15, 2023 1:00 PM - Nov 16, 2023 6:40 PM

DIA Innovating Clinical Trials in Europe

This year's must-attend virtual live conference for pharmaceutical innovators and clinical researchers alike!

Session 2: Platform Trials in Europe: EU PEARL Project and the ACT EU Vision

Session Chair(s)

Daniel  Millar, MBA

Daniel Millar, MBA

Senior Director, Strategic Business Transformation

Johnson & Johnson, United States

The European Union-Patient-cEntric clinicAl tRial pLatform (EU-PEARL) initiative has developed new methodologies and tools to expand the master protocol approach into Integrated Research Platforms (IRPs) in collaboration with patient representatives and through consultation with FDA and EMA stakeholders. This session will highlight the deliverables now available to the clinical trial community, the path forward for IRPs in Europe, and the connection to the broader Accelerating Clinical Trials (ACT) EU vision.


Cecile  Spiertz, MSc

Integrated Research Platform concept and key deliverables from EU PEARL

Cecile Spiertz, MSc


Stefan  Gold

IRP for Major Depressive Disorder

Stefan Gold

Charité Universitätsmedizin Berlin, Germany


Fanni-Laura   Mantyla

IRP for Major Depressive Disorder

Fanni-Laura Mantyla

Patient Community Representative, Switzerland

Franz  Koenig, MSc

Study Design and Statistical Methods for platform trials, including Regulatory guidance

Franz Koenig, MSc

Medical University of Vienna, Austria

Associate Professor

Benjamin  Hofner, PhD

Study Design and Statistical Methods for platform trials, including Regulatory guidance

Benjamin Hofner, PhD

Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Germany

Head of Data Science and Methods

Olga  Kholmanskikh Van Criekingen, MD, PhD

Regulatory Perspective on IRPs: Experience with EU CTR to support Complex Clinical Trials.

Olga Kholmanskikh Van Criekingen, MD, PhD

Federal Agency for Medicines and Health Products, Belgium

Clinical assessor

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.